1. Home
  2. ASMB vs ENVX Comparison

ASMB vs ENVX Comparison

Compare ASMB & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$19.95

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Logo Enovix Corporation

ENVX

Enovix Corporation

N/A

Current Price

$1.82

Market Cap

612.3M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
ENVX
Founded
2005
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
612.3M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
ASMB
ENVX
Price
$19.95
$1.82
Analyst Decision
Strong Buy
Buy
Analyst Count
5
12
Target Price
★ $51.20
$9.75
AVG Volume (30 Days)
201.9K
★ 9.5M
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 91.78
40.94
EPS
N/A
★ N/A
Revenue
N/A
★ $31,821,000.00
Revenue This Year
N/A
$23.31
Revenue Next Year
N/A
$93.03
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 37.91
52 Week Low
$19.20
$2.19
52 Week High
$39.71
$9.19

Technical Indicators

Market Signals
Indicator
ASMB
ENVX
Relative Strength Index (RSI) 42.68 33.68
Support Level $19.25 N/A
Resistance Level $21.65 $3.01
Average True Range (ATR) 1.16 0.35
MACD 0.37 -0.08
Stochastic Oscillator 26.65 4.76

Price Performance

Historical Comparison
ASMB
ENVX

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

Share on Social Networks: